Due primarily to cell sourcing issues, many in the field of tissue engineering have opted to create scaffolds that promote in situ regeneration, using the body as both the bioreactor and the cell source for the remodeling of scaffolds, resulting in the formation of native tissue. This practice raises many concerns, with the body's immune response to such an implant often being neglected as a potential problem in preliminary design and biocompatibility testing. More importantly, what happens over time in terms of the immune responses as the biodegradable scaffold structures being utilized to promote in situ regeneration begin to degrade, forming structural fragments and degradation products? In summary, immune response evaluations are critical considerations that must be conducted when evaluating bioresorbable scaffolds. In addition, it is essential that these evaluations analyze materials for their potential dose-response and time-course effects on the various components of innate and acquired immunity.
References
1.
RemesA, WilliamsDF. Immune response in biocompatibility. Biomaterials.1992; 13(11): 731–43.
2.
WhiteKLJr., KlykkenPC. The non-specific binding of immunoglobulins to silicone implant materials: the lack of a detectable silicone specific antibody. Immunol Invest.1998 Jul-Sep; 27(4–5): 221–35.
3.
BradleySGSubchronic 10 day immunotoxicity of polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice. Drug Chem Toxicol.1994; 17(3): 175–220.
4.
BradleySGImmunotoxicity of 180 day exposure to polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice. Drug Chem Toxicol.1994; 17(3): 221–69.
5.
KlykkenPC, WhiteKL. The adjuvancy of silicones: Dependency on compartmentalization. Current Topics in Microbiology and Immunology.1996; 210: 113–21.
6.
WhiteKL. Silicone gel and animal models of autoimmune disease. Clin Immunol Immunopathol.1998; 87(3): 105–6.
7.
WhiteKLEffects of hydroxyethylstarch (Hespan), a plasma expander, on the functional activity of the reticuloendothelial system. Comparison with human serum albumin and pyran copolymer. Drug and Chemical Toxicology.1986; 9: 305–22.
8.
WhiteKLImmunotoxicological investigations in the mouse: General approach and methods. Drug and Chemical Toxicology.1985; 8: 299–332.
9.
WhiteKL. Scientifically based immunotoxicological testing strategies for chemicals (industiral/environmental/pesticides). International Workshop on Environmental Immunotoxicology and Human Health, Oxford. Human & Experimental Toxicology.1995; 14: 141–2.
10.
BrownEJ, GreshamHD. Phagocytosis. In: PaulWE, editor. Fundamental Immunology. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2003. p. 1105–26.
11.
AndersonJM, MillerKM. Biomaterial biocompatibility and the macrophage. Biomaterials.1984 Jan; 5(1): 5–10.
12.
MitchellRN. Innate and Adaptive Immunity: The Immune Response to Foreign Materials. In: RatnerBD, editors. Biomaterials Science: An Introduction to Materials in Medicine. 2nd ed. San Diego, CA: Elsevier Academic Press; 2004. p. 304–18.
13.
Kottke-MarchantKVascular graft-associated complement activation and leukocyte adhesion in an artificial circulation. J Biomed Mater Res.1987 Mar; 21(3): 379–97.
14.
MillerKM, AndersonJM. In vitro stimulation of fibroblast activity by factors generated from human monocytes activated by biomedical polymers. J Biomed Mater Res.1989 Aug; 23(8): 911–30.
15.
MillerKM, AndersonJM. Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. J Biomed Mater Res.1988 Aug; 22(8): 713–31.
16.
MillerKMCharacterization of biomedical polymer-adherent macrophages: interleukin 1 generation and scanning electron microscopy studies. Biomaterials.1989 Apr; 10(3): 187–96.
17.
MillerKM, Rose-CapraraV, AndersonJM. Generation of IL-1–like activity in response to biomedical polymer implants: a comparison of in vitro and in vivo models. J Biomed Mater Res.1989 Sep; 23(9): 1007–26.
18.
CardonaMA, SimmonsRL, KaplanSS. TNF and IL-1 generation by human monocytes in response to biomaterials. J Biomed Mater Res.1992 Jul; 26(7): 851–9.
19.
BrodbeckWGBiomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. Cytokine.2002 Jun 21; 18(6): 311–9.
ButlerLCharacteristics of cellular immune responses to collagen type I or collagen type II. Cell Immunol.1986 Jul; 100(2): 314–30.
24.
LynnAK, YannasIV, BonfieldW.Antigenicity and immunogenicity of collagen. J Biomed Mater Res B Appl Biomater.2004 Nov 15;71(2): 343–54.
25.
KresinaTFImmunoglobulin G-induced experimental chronic immune synovitis: cell-mediated immunity to native interstitial collagen molecules and their constituent polypeptide chains. Cell Immunol.1984 Sep; 87(2): 504–16.
26.
van LuynMJModulation of the tissue reaction to biomaterials. II. The function of T cells in the inflammatory reaction to crosslinked collagen implanted in T-cell-deficient rats. J Biomed Mater Res.1998 Mar 5; 39(3): 398–406.
27.
KhouwIMEnzyme and cytokine effects on the impaired onset of the murine foreign-body reaction to dermal sheep collagen. J Biomed Mater Res.2001 Feb; 54(2): 234–40.
28.
KhouwIMForeign-body reaction to dermal sheep collagen in interferon-gamma-receptor knock-out mice. J Biomed Mater Res.2000 May; 50(2): 259–66.
BarrowsTH. Synthetic Bioabsorbable Polymers. In: SzycherM., editor. High Performance Biomaterials.Lancaster, PA: Technomic Publishing Co., Inc.; 1991. p. 243–57.
33.
AndradeMG, WeissmanR, ReisSR. Tissue reaction and surface morphology of absorbable sutures after in vivo exposure. J Mater Sci Mater Med.2006 Oct; 17(10): 949–61.
34.
UffCRInfluence of soluble suture factors on in vitro macrophage function. Biomaterials.1995 Mar; 16(5): 355–60.
35.
BolandEDElectrospinning polydioxanone for biomedical applications. Acta Biomaterialia.2005 Jan; 1(1): 115–23.
36.
BolandEDElectrospinning of bioresorbable polymers for tissue engineering scaffolds. Polymeric Nanofibers; 2006. p. 188–204.
37.
BolandEDUtilizing acid pretreatment and electrospinning to improve biocompatibility of poly(glycolic acid) for tissue engineering. Journal of Biomedical Materials Research Part B-Applied Biomaterials.2004 Oct; 71B(1): 144–52.
38.
KenawyERRelease of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. Journal of Controlled Release.2002 May; 81(1–2): 57–64.
39.
BarnesCPFeasibility of Electrospinning the Globular Proteins Hemoglobin and Myoglobin. Journal of Engineered Fibers and Fabrics.2006; 1(2): 16–29.
40.
BolandEDElectrospinning collagen and elastin: Preliminary vascular tissue engineering. Frontiers in Bioscience.2004 May; 9: 1422–32.
41.
MatthewsJAElectrospinning of collagen type II: A feasibility study. Journal of Bioactive and Compatible Polymers.2003 Mar; 18(2): 125–34.
42.
MatthewsJAElectrospinning of collagen nanofibers. Biomacromolecules.2002 Mar-Apr; 3(2): 232–8.
43.
WnekGEElectrospinning of nanofiber fibrinogen structures. Nano Letters.2003 Feb; 3(2): 213–6.
44.
BarnesCPPreliminary Investigation of Electrospun Collagen and Polydioxanone for Vascular Tissue Engineering Applications. International Journal of Electrospun Nanofibers and Applications.2007; 1(1): 73–87.
45.
SmithMJSuture-Reinforced Electrospun Polydioxanone – Elastin Small-Diameter Tubes for Use in Vascular Tissue Engineering: A Feasibility Study. Acta Biomater. In Press.
46.
SandersJERelative influence of polymer fiber diameter and surface charge on fibrous capsule thickness and vessel density for single-fiber implants. J Biomed Mater Res.2003; 65A: 462–7.
47.
SandersJE, StilesCE, HayesCL. Tissue response to single-polymer fibers of varying diameters: Evaluation of fibrous encapsulation and macrophage density. J Biomed Mater Res.2000; 52: 231–7.
48.
LusterMIDevelopment of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program Guidelines for Immunotoxicity Evaluation in Mice. Fundam Appl Toxicol.1988; 10: 2–19.
49.
GuoTLGlycidol Modulation of the Immune Responses in Female B6C3F1 Mice. Drug and Chemical Toxicology.2000; 23: 433–57.
50.
MishellRI, DuttonRW. Immunization of normal mouse spleen cell suspensions in vitro. Science.1966 Aug 26; 153(739): 1004–6.
51.
Marciano-CabralFDelta-9-Tetrahydrocannabinol, the Major Psychoactive Component in Marijuana, Inhibits Macrophage Cehmotaxis to Acanthamoeba. J Eukaryot Microbiol.2006; 53(S1): S15–S7.
52.
GuoTLImmunotoxicity of sodium bromate in female B6C3F1 mice: a 28–day drinking water study. Drug Chem Toxicol.2001 May; 24(2): 129–49.
53.
ReynoldsCW, HerbermanRB. In vitro augmentation of rat natural killer (NK) cell activity. J Immunol.1981 Apr; 126(4): 1581–5.
54.
GuoTLGenistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. Toxicol Appl Pharmacol.2002 Jun 15; 181(3): 219–27.
55.
LusterMIRisk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol.1992; 18(2): 200–10.
56.
HolsappleMPSuppression of cell-mediated immunocompetence after subchronic exposure to diethylstilbestrol in female B6C3F1 mice. J Pharmacol Exp Ther.1983; 227(1): 130–8.
57.
TempleLComparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam Appl Toxicol.1993 Nov; 21(4): 412–9.
58.
LusterMIRisk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam Appl Toxicol.1993; 21(1): 71–82.
